15.10.2024

Successful M&A Exit Readiness for LynxCare, the leading European AI-powered clinical data platform

October 2024, The Technology & Software industry sector team of Blue Tree Group – Investment Banking successfully advised key investors – MTIP, with participation from Elaia and early-stage investors Heran Partners, BTOV/ MATTERWAVES – of Belgian AI-powered clinical data platform, LynxCare, in M&A Market Sounding. 

Founded in 2015 by Georges De Feu and Dries Hens, LynxCare enables hospitals to unlock legacy data and provide real-world insights on treatment performance, enhancing clinical decision-making. The platform leverages AI and Natural Language Processing (NLP) to improve patient outcomes.

The successful advisory of LynxCare in the second quarter of 2024 marks the 8th market sounding for the Technology & Software industry team at Blue Tree Group-  Investment Banking, which specialises in M&A and financing advisory for European venture capital firms. It is also the fourth advisory project in the rapidly growing health-tech venture capital segment.